Evidence map›Paper›PMID 8788937›Full record

ArticleThe Journal of physiology1995

Apamin-sensitive K+ channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries.

M E Murphy, J E Brayden

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 169 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Dynamic Ca(2+) signal modalities in the vascular endothelium.Microcirculation (New York, N.Y. : 1994) · 2012
    Review
  8. Review
  9. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.Pflugers Archiv : European journal of physiology · 2010
    Review
  10. Article
  11. Possible Involvement of Ca Activated K Channels, SK Channel, in the Quercetin-Induced Vasodilatation.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2009
    Article
  12. Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone.American journal of physiology. Heart and circulatory physiology · 2009
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M E MurphyDepartment of Pharmacology, University of Vermont Medical Research Facility, Colchester 05446, USA.
J E Brayden
University of Vermont Medical Center · US

Funding

SYNERGISM BETWEEN MODULATORS OF CEREBROVASCULAR TONEF32HL008648 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MURPHY, MICHAEL E · 1992 to 1994
–
NEUROGENIC VASODILATION--MEDIATORS AND MECHANISMSR01HL035911 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BRAYDEN, JOSEPH ELLIOTT · 1989 to 1993
–
NEUROGENIC VASODILATION: MEDIATORS AND MECHANISMSR23HL035911 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BRAYDEN, JOSEPH ELLIOTT · 1986 to 1988
–
NHLBI NIH HHS HL08648NHLBI NIH HHS HL35911
6 · The paper itself

Abstract

1. Vascular endothelial cells release a variety of substances which affect the membrane potential and tone of underlying vascular smooth muscle. In the presence of N omega-nitro-L-arginine to inhibit nitric oxide synthase and indomethacin to inhibit cyclo-oxygenase, acetylcholine (ACh; EC50 approximately 1 microM) elicited the release of an endothelium-derived hyperpolarizing factor (EDHF) in rabbit mesenteric arteries. 2. The hyperpolarization due to EDHF was blocked by apamin (IC50 approximately 0.3 nM), and by other inhibitors of the apamin-sensitive K+ channel (10 nM scyllatoxin, 100 microM d-tubocurarine, 300 microM gallamine) in the presence of indomethacin and N omega-nitro-L-arginine. The hyperpolarization was not blocked by glibenclamide (5 microM), iberiotoxin (10 nM), tetraethylammonium (1 mM), barium (500 microM), 4-aminopyridine (500 microM), ouabain (10 microM), bumetanide (10 microM), or nimodipine (100 nM). 3. In the presence of apamin and N omega-nitro-L-arginine, but the absence of indomethacin, ACh triggered a hyperpolarization that was blocked by glibenclamide, an inhibitor of ATP-sensitive K+ (KATP) channels. A similar glibenclamide-sensitive hyperpolarization was caused by Iloprost, a stable analogue of prostacyclin. 4. In experiments which distinguished the effects of EDHF, prostanoids and nitric oxide, hyperpolarizations and/or relaxations triggered by ACh were antagonized by muscarinic antagonists, the relative potencies (atropine approximately 4-DAMP > pirenzepine) of which indicated that the release of all three endothelium-derived factors was mediated by M3 receptors. 5. Our results suggest that ACh stimulates M3 receptors on endothelial cells, triggering the release of nitric oxide and prostanoids, which hyperpolarize underlying smooth muscle by activation of KATP channels, and the release of an EDHF, which hyperpolarizes smooth muscle through the activation of apamin-sensitive K+ (KAS) channels.

Indexed as

AcetylcholineAnimalsApaminBiological FactorsEndothelium, VascularIn Vitro TechniquesMembrane PotentialsMesenteric ArteriesMuscarinic AntagonistsMuscle RelaxationMuscle, Smooth, VascularNeuromuscular Depolarizing AgentsPatch-Clamp TechniquesPotassium ChannelsRabbitsReceptors, MuscarinicAcetylcholineApaminBiological Factorsendothelium-dependent hyperpolarization factorMuscarinic AntagonistsNeuromuscular Depolarizing AgentsPotassium ChannelsReceptors, Muscarinic

Identifiers

PMID8788937
PMCPMC1156842
OpenAlexW2048148521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.